Page last updated: 2024-10-18

dihydroxyphenylalanine and Precancerous Conditions

dihydroxyphenylalanine has been researched along with Precancerous Conditions in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Precancerous Conditions: Pathological conditions that tend eventually to become malignant.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Halldin, MM1
Cook, WS1
Kawashima, T1
Crutcher, WA1
Fukuyama, K1
Shanin, AP1

Reviews

1 review available for dihydroxyphenylalanine and Precancerous Conditions

ArticleYear
[A review of the literature concerning the etiology, pathogenesis, histogenesis, clinical picture and treatment of skin melanomas during the past 5 years].
    Voprosy onkologii, 1971, Volume: 17, Issue:4

    Topics: Carbon Isotopes; Dihydroxyphenylalanine; Golgi Apparatus; Humans; Melanoma; Mitochondria; Nevus; Nev

1971

Other Studies

1 other study available for dihydroxyphenylalanine and Precancerous Conditions

ArticleYear
Identification of 5-S-cysteinyldopa by high performance liquid chromatography in biopsies from patients with dysplastic melanocytic nevi.
    Cancer research, 1987, Jan-15, Volume: 47, Issue:2

    Topics: Biopsy; Chromatography, High Pressure Liquid; Cysteinyldopa; Dihydroxyphenylalanine; Humans; Melanoc

1987